Aspire Private Capital, LLC Emergent Bio Solutions Inc. Transaction History
Aspire Private Capital, LLC
- $398 Million
- Q4 2024
Shares
3 transactions
Others Institutions Holding EBS
# of Institutions
157Shares Held
33.7MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$41.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$36.9 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$27.1 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$24.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$20.8 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $542M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...